• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The in-vitro Effects of Arbidol Hydrochloride Against 2009 New Influenza Virus A (H1N1)

tetano

Editor, Senior Moderator
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Apr;34(2):126-9.
The in-vitro Effects of Arbidol Hydrochloride Against 2009 New Influenza Virus A (H1N1).
Xing-Quan Z, Jun-Peng D, Bai-Qiang C.
Source

Infectious Disease Division, Medical School, University of California, San Diego L Jolla CA 92093,USA.
Abstract

Objective To detect the in-vitro effects of arbidol hydrochloride against 2009 new influenza virus A (H1N1). Methods The activity of arbidol hydrochloride against 2009 new influenza virus A (H1N1) was determined in MDCK cell cultures. Hemagglutination assay, observation of cytopathic effects, RT-PCR and quantitative RT-PCR tests were performed for determination of virus titers. Inhibition concentration 50% and cytotoxic concentration 50% were calculated with Chou's Menu of Dose-Effect Program. Results Arbidol hydrochloride showed low cytotoxicity (cytotoxic concentration 50%>100 μmol/L)and significant anti-2009 new influenza virus A (H1N1) activity in cell cultures. Inhibition concentration 50% were (5.5±0.9), (3.4±0.8), and (1.5±0.2) μmol/L in hemagglutination assay, cytopathic effect test, and quantitative RT-PCR assay, respectively. Conclusion Arbidol has low cytotoxicity and high anti-virus activity and can effectively trigger the activities of interferon and immune response, and therefore can be a valuable anti-influenza virus drug.

PMID:
22776596
[PubMed - in process]

Free full text

http://www.ncbi.nlm.nih.gov/pubmed/22776596
 
Back
Top Bottom